Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables) - Service-Based Vesting Condition Options [Member]

12 Months Ended

Nov. 30, 2020

Variables used to determine the fair value of the options granted for the years ended November 30, 2020 and November 30, 2019 are as follows:

	2020	2019
Weighted average values:
Expected dividends	0%	0%
Expected volatility	59.32%	64.02%
Risk free interest rate	1.12%	1.55%
Expected life	7.9 years	8.4 years

Stock Option Activity

Stock option activity for options with only service-based vesting conditions for the year ended November 30, 2020, was as follows:

				Weighted		Weighted Average Remaining
				Average		Contractual		Aggregate
	Options			Exercise Price		Term (Years)		Intrinsic Value
Outstanding at November 30, 2019		1,089,774		$	3.30	3.91		$	4,648,111
Granted		105,169			7.73				10,866
Exercised		(20,000	)		2.05				102,800
Expired/forfeited		—			—				—
Outstanding at November 30, 2020		1,174,943		$	3.72		3.42	$	4,502,324
Exercisable at November 30, 2020		1,081,563		$	3.37		3.01	$	4,494,532

Significant Option Groups Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at November 30, 2020 and related price and contractual life information are as follows:

	Outstanding						Exercisable
			Weighted Average
			Remaining		Weighted				Weighted
Range of Exercise Prices	Outstanding		Contractual Life (Years)		Average Exercise Price		Outstanding		Average Exercise Price
$1.01 to $2.00		422,500		1.09	$	1.73		422,500	$	1.73
$2.01 to $3.00		245,000		1.10	$	2.78		245,000	$	2.78
$3.01 to $4.00		204,729		5.23	$	3.14		204,729	$	3.14
$6.01 to $7.00		3,833		5.59	$	6.52		2,944	$	6.51
$7.01 to $8.00		291,881		7.38	$	7.64		206,040	$	7.62
$9.01 to $10.00		7,000		6.69	$	9.10		350	$	9.10
		1,174,943		3.42	$	3.72		1,081,563	$	3.37

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of November 30, 2020, and changes during the fiscal year then ended, is presented below:

				Weighted Average
				Grant-Date
	Options			Fair Value
Non-vested at November 30, 2019		125,234		$	4.70
Granted		105,169			4.66
Vested		(137,023	)		4.70
Forfeited		—			—
Non-vested at November 30, 2020		93,380		$	4.65